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Introduction: The aim of this study was to evaluate the clinical and radiological outcomes of total hip
arthroplasty (THA) in patients with Ankylosing Spondylitis (AS).
Patients and methods: One hundred ﬁve hips of 61 AS patients (mean age: 41.3 ± 10.2 years) who un-
derwent THA between 1997 and 2012 were included into the study. Dorr's classiﬁcation of proximal
femoral geometry, acetabular protrusio, bone ankylosis, acetabular protrusion, Brooker classiﬁcation of
heterotopic ossiﬁcation (HO), Gruen and Charnley classiﬁcations of implant loosening were used in
radiographic assessments. Patients were called back to return for an additional long-term follow-up for
functional assessment.
Results: Cementless total hip arthroplasty was used in 83 hips (79%) and cemented TKA was used in 22
hips (21%). The overall rate of aseptic loosening was 7.6% at a mean follow-up of 5.4 years. Femoral
loosening was statistically similar in cemented and cementless femoral components (14% vs. 8%,
p ¼ 0.089). Acetabular component loosening was statistically higher in patients with any degree of HO
(p ¼ 0.04). Regardless of the type of femoral implant (cemented or cementless), femoral component
loosening was higher in Dorr's type C patients (p ¼ 0.005). The average pre-operative HSS was
46.6 ± 16.3, and it improved to 80.7 ± 18.7 at last follow-up (p < 0.01).
Conclusion: Revision incidence was similar in between ankylosed and non-ankylosed hips. While
complication rates are high, signiﬁcant functional improvement can be achieved after THA in patients
with AS.
© 2016 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Ankylosing spondylitis (AS) is a prototype of seronegative
spondyloarthropathies and characterized by progressive erosion of
effected joints as a result of inﬂammation.1 Onset of AS often occurs
at a relatively young age and that is accepted as a greater risk of hip
involvement.2 The incidence of hip involvement in AS is between
30% and 50% of patients, and 47e90% of patients who have such
involvement have it bilaterally.3e5 In addition to hip involvement,
spine stiffness and intra-thoracic problems can cause severe
disability in AS patients.3glam).
ciation of Orthopaedics and
s and Traumatology. Publishing seDisease modifying anti-rheumatic drugs (DMARDs) such as
sulfasalazine and methotrexate have limited in treatment of hip
problems.6,7 Standard treatment option for advanced hip disease is
THA.4 Indications of THA are refractory pain, disability and radio-
logic evidence of damage in hips, regardless of age.3 Reportedmean
implant survival at 8.5 years follow-up was 85.9% and all patients
were satisﬁed with using cementless THA.8 Also cemented THA in
AS is provided satisfactory clinical and radiologic outcome, with a
71% survival rate at 27 years follow-up.4
The aim of this study is to evaluate the clinical and radiologic
outcomes of cemented and cementless THA in patients with AS at a
single institution. We also identiﬁed the factors that are associated
with poor outcome.rvices by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
Fig. 1. Pre-operative x-ray of a patient with bony ankylosis.
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This is an institutional review board (IRB) approved study.
Retrospective review was included all patients diagnosed with hip
involvement of AS and treated with THA at a single institution from
1997 to 2012. Patients with minimum 2 year follow up were
included. Charts were analyzed for clinical and radiologic features
preoperatively and at last follow-up.
The radiographic study involved the review of anteroposterior
(AP) both hips x-ray taken pre-operatively, immediate post-
operative period and at last follow-up. Preoperative x-ray assess-
ments were included Dorr's classiﬁcation,9 acetabular protrusio
and bone ankylosis. Acetabular protrusion was deﬁned as femoral
head in that the medial aspect of the femoral cortex is medial to the
ilioischial line.10 Brooker classiﬁcation11 of heterotopic ossiﬁcation
(HO), Gruen12 and Charnley13 classiﬁcations of implant loosening
were assessed at last follow-up x-ray.
In addition to the chart and radiographic review, patients were
called back to return for additional long-term follow up. Those able
to return (32 patients, 59 hips) had additional radiographs, func-
tional outcome assessment with Harris Hip Score (HHS).14 Bath
Ankylosing Spondylitis Disease Activity Index (BASDAI) was also
assessed to evaluate the activity of disease.15
Statistical analysis was performed using Microsoft Excel (Red-
mond, WA) and MedCalc B-8400 (Ostend, Belgium). Categorical
data were compared using chi-square test, and continuous data
using two-sample Student's t-test. A p value of 0.05 was consid-
ered signiﬁcant. KaplaneMeier survival analysis with 95% conﬁ-
dence intervals (CI) was used to assess implant survival, with
clinical or radiological failure as the endpoint.Fig. 2. Four years after bilateral simultaneous THA.Results
There were 61 patients (50 male, 11 female) with 105 affected
hips (72% bilateral, 28% unilateral). The average patient age at
surgery was 41.3 ± 10.2 years old. The age of patients at THAwas as
follows: <30 years for 14 patients (23 hips), 31e50 years for 41
patients (73 hips) and >50 years for 6 patients (9 hips) (Graph 1).
The younger age at diagnosis (<30 years old) of AS was correlated
with younger age at THA (p < 0.05). Bone ankylosis was detected in
37 (35%) and acetabular protrusion was noticed in 18 (17%) hips in
pre-operative radiographs (Figs. 1e4) (Table 1). The mean pre-
operative ﬂexion contracture was 20.3±21.8. In patients without
ankylosis, the mean total hip range of motion (ROM) was
67.8±25.7.
Cementless total hip arthroplasty was used in 83 hips (79%) and
cemented TKA was used in 22 hips (21%) though lateral HardingeGraph 1. Age distribution at surgery (THA).
Fig. 3. Pre-operative x-ray of a patient with protrusio acetabuli.approach. Dorr's classiﬁcation was used as a guide for femoral
component selection. In all Dorr's type A patients, cementless
femoral component was used, but in the majority of Dorr's type C
patients (60%) cemented femoral components were selected. The
trend for using cementless type femoral components were
increased after 2002 as a result of surgeon preference.
Fig. 4. Six years after right side, ﬁve years after left side THA.
Table 2
Functional improvement after surgery.
Pre-operative Post-operative p Value
Harris Hip Score (HHS) 46.6 ± 16.3 80.7 ± 18.7 p < 0.01
Bath Ankylosing
Spondylitis Disease
Activity Index (BASDAI)
7.3 ± 1.6 4.1 ± 1.1 p < 0.01
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Superﬁcial wound infection in 3 hips, deep infection in 1 hip, peri-
prosthetic fracture in 2 hips, sciatic neuropraxy in 1 hip, dislocation
in 2 hips. All peri-prosthetic fractures were treated with plate and
cable ﬁxation. After close reduction of two acute dislocations, a
major instability was noted and treated with revision including
realignment of THA components. The sciatic nerve palsies were
resolved in two months. Superﬁcial wound infections were treated
with antibiotics and daily dressing successfully (Table 3).
Heterotopic ossiﬁcation (HO) was found in 14 hips (13.3%), with
Brooker class 1 in 9 hips, Brooker class 2 in 2 hips, Brooker class 3 in
2 hips and Brooker class 4 in 1 hip (Fig. 5). Once the HO was
diagnosed by x-ray, 75 mg/day indomethacin was initialed.
In the late post-operative period, radiographic loosening of
femoral component was present in 6 stems, with subsidence of
>5 mm was present in 2 patients according to Gruen classiﬁcation
(Fig. 6). For the acetabular component, radiographic loosening was
present in 4 patients according to Charnley classiﬁcation. In 2 pa-
tients, radiographic loosening was present both in femoral and
acetabular components. Femoral loosening was statistically similar
in cemented and cementless femoral components (14% vs. 8%,
p ¼ 0.089). Acetabular component loosening was statistically
higher in patients with any degree of HO (p ¼ 0.04). Regardless of
the type of femoral implant (cemented or cementless), femoral
component loosening was higher in Dorr's type C patients
(p ¼ 0.005).
Revision surgery was performed in 17 hips (16.1%). The mean
time after the ﬁrst operation to the ﬁrst revisionwas 5.1 ± 1.8 years.
Five hip revisions were for late peri-prosthetic infection, and of
these, implants were needed to be removed and converted to a
Girdlestone pseudarthrosis after several debridement-irrigations,
revisions and prolonged antibiotic regimes in two patients. Eight
hips were revised because of aseptic implant loosening. Acetabular
augments, such as acetabular cup-cage or ring, were used in 4 hips
for major column defects and pelvic discontinuity. In these cases,Table 1
Demographic and radiological features.
Patients 61 patients (50 male, 11 fem
The average patient age at surgery 41.3 ± 10.2
Cemented (22 hips e 21%)
Acetabular protrusion 7
Bone ankylosis 11
Heterotopic ossiﬁcation (HO) 5
Aseptic implant loosening Femoral
2depending on the severity of bone loss, morcellised allograft was
used for reconstruction of the medial wall for possible further in-
terventions. Dislocation was not seen in late post-operative period.
Two peri-prosthetic fractures were treated with plate and cable
ﬁxation. Two patients were underwent removal of HO because of
serious limitation of hip motion. These two patients were received
a single perioperative dose of 700 cGy radiotherapy on the day of
surgery. Two patients had spine osteotomy after the hip pro-
cedures. Revision incidence was similar in between patients who
had pre-operative bony ankylosis and a mobile hip joint (9% vs. 7%,
p ¼ 0.40) (Table 3).
The average pre-operative HSS was 46.6 ± 16.3, and it improved
to 80.7± 18.7 at last follow-up (p < 0.01). The average BASDAI score,
which shows the activity of disease, was 7.3 ± 1.6, and it decreased
to 4.1 ± 1.1 at last follow-up (p < 0.01) (Table 2). KaplaneMeier
survival rate for two years after surgery was 97.7% (95% CI). At a
mean follow-up of 5.4 ± 3.3 years, ﬁnal examination showed 78% of
the hips had minimal or no pain, 68.8% patients had good-excellent
function.
Discussion
Ankylosing spondylitis is a chronic rheumatologic diseasewhich
affects 1% of the population. Hip involvement in AS is between 30%
and 50%, and the disease may be bilateral in 47e90% of patients.3,4
Most of the reported studies have either a small group of patient or
short follow-up. The study by Joshi et al4 and Bhan et al8 are the
largest reported series to date respectively (181 hips with an
average of 10.3 years follow up; 92 hips with an average of 8.5 years
follow-up). Our study involved 105 hips in 61 patients with an
average follow-up of 5.4 years. Our aim was to evaluate the mid-
term clinical and radiologic results of THA in patients with AS,
and to identify the factors that are associated with poor outcome.
Disabling pain is the most common indication for THA. Patients
with bony ankylosis usually do not have pain, but functional limi-
tation and presence of severe deformity can be indications of THA
in AS.3,8 In our study, bony ankyloses was present in 35% of all hips
pre-operatively. Although these patients were satisﬁed with the
improvement of hip function, some of themwere reported hip and
groin pain post-operatively.
A high incidence of HO after THA has been reported in patients
with AS (9e77%).4,16e18 Re-ankylosis rates has been reported high
and correlate with ankyloses of the hip before THA.4,18e21 In our
study, HO rate after THA was 13.3% at an average follow-up of 5.4
years after surgery. Some authors suggest routine prophylaxis ofale) (72% bilateral, 28% unilateral)
Non-cemented (83 hips e 79%)
11
26
9
Acetabular Femoral Acetabular
2 4 3
Table 3
Complications.
Early (within the post-operative ﬁrst year) Late (after the ﬁrst post-operative year)
Cemented Cementless Cemented Cementless
Superﬁcial wound infection 1 2 0 0
Deep infection 0 1 2 3
Girdlestone pseudarthrosis 0 0 1 1
Peri-prosthetic fracture 0 2 0 2
Sciatic neuropraxy 0 1 0 0
Dislocation 1 1 0 0
Aseptic implant loosening (number of hips) 0 0 4 4
Heterotopic ossiﬁcation (HO) 1 1 4 8
Fig. 5. Brooker type 1 heterotopic ossiﬁcation on the right and type 2 on the left side.
Fig. 6. Bone-cement demarcation of left femur was present in the zones on Gruen I-IV-
V-VI-VII. Fracture of the cement mantle was seen at the tip of the femoral component
on the left side.
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700 cGy radiation therapy (RT) one day before or the day of surgery
in selected patients, for prevention of HO after THA in high risk
patients.16,22 We routinely used indomethacin 75 mg per day post-
operatively for one month for HO prevention and pain relief,
whereas RT in only revision surgeries.
Surgeons may have some concerns about long-term outcome in
young patients who undergoTHA, several reports have shown good
to excellent functional results with longer survivorship of the
implant in AS patients.4,8,23,24 In our study, 16.1% of all hips were
undergone a second surgical intervention. The choice of cementedor un-cemented implant is important for long-term outcome and
implant survival in this young patient group.8,19,25,26 Recent liter-
ature has shown that un-cemented prosthetic designs have the
potential of bone ingrowth and may increase the implant survival
rates.27e29 Cementless THAwas used in 79% of the hips in our study.
Although, femoral loosening was statistically similar, cementless
ones weremore prone to loosening at a mean follow up of 5.4 years
(p ¼ 0.08).
Cementless prosthesis can still achieve good outcomes without
signiﬁcant proximal femoral morphologic changes, the AS patients
were found to have severe osteoporosis in the upper femur,
therefore cemented prosthetic designs were recommended for AS
patients with severe osteoporosis.26 Class C bone lacks structural
integrity, including osteoporotic degradation of the medial and
posterior cortices and a wide intramedullary canal, leading to
increased risk of loosening of a ﬁxated implant as a result of
compromised bone ingrowth between the bone and implant.9,30
Dorr type C femurs are found predominantly in older women
with lower body weight. These femurs have structural and cellular
compromise and are less favorable for implant ﬁxation.31 Cemen-
ted prostheses were predominantly used in Dorr's type C and
osteoporotic patients, versus, the usage of cementless were trend to
be higher after 2002 in this study. Surgeon preference and patients
anatomy were the primary factors for choosing cemented or
cementless implants.
Pelvic abnormalities and external rotation deformity may cause
implant mal-position during surgery.8,24,32 Due to these abnor-
malities, surgeons are prone to position the acetabular component
more anteverted and vertical. Implant malposition, soft tissue
contractures and lateral Hardinge approach may lead to anterior
dislocation of the hip.33 All the two dislocations were anterior in
our patients.
The overall rate of aseptic loosening were 11.4% at a mean
follow-up of 5.4 years in our series, which is slightly higher than
the reported literature for AS patients.8,20,21,24 In a systematic re-
view of the literature Zwartele et al was reported the overall
failure rate ratio (cementless/cemented) for the cup was 0.6 (95%
CI: 0.14e2.60) and for the stem 0.71 (95% CI: 0.06e8.55), both
favoring cementless ﬁxation in Rheumatoid Arthritis.34 The studies
on the Scandinavian countries register show better results for
cementless femoral stems both in young and in older patients with
inﬂammatory arthritis.34 Some authors associate higher loosening
rats in AS patients with the stiffness in spine and increased forces
around the hip joint.19 Implant malposition as a result of pelvic
deformities may also lead to early aseptic loosening in these
patients.
In conclusion, patients with Dorr's type C are prone to femoral
component loosening and patients who had HO are prone to
acetabular loosening in AS. Revision incidence was similar in be-
tween ankylosed hips and hips had motion pre-operatively. Sur-
vival rates of implants were shorter in AS patients than reported
Y. Saglam et al. / Acta Orthopaedica et Traumatologica Turcica 50 (2016) 443e447 447survivals for primary THA in patients with non-inﬂammatory
arthritis in the current literature. Complication rates are high but
signiﬁcant functional improvement can be achieve after THA in
patients with AS.
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